How do bacteria resist human antimicrobial peptides?

Trends in Microbiology

Volumn 10, Issue 4, 2002, Pages 179-186

  Peschel, Andreas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CATHELICIDIN; LIPID A; PEPTIDE; PHOSPHOLIPID; PROTEINASE; TEICHOIC ACID; THROMBOCIDIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ATTENUATION; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CELL ENERGY; CHEMICAL MODIFICATION; GENE CONTROL; HUMAN; IMMUNE SYSTEM; MOLECULAR EVOLUTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA ENTERICA; SKIN PROTECTION; STAPHYLOCOCCUS AUREUS; THROMBOCYTE;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; LIPID A; MOLECULAR SEQUENCE DATA; PHOSPHOLIPIDS; TEICHOIC ACIDS; VIRULENCE;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA; SALMONELLA; SALMONELLA ENTERICA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0036532403     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(02)02333-8     Document Type: Review

References (66)

1. Antimicrobial peptides in mammalian and insect host defence
2. Peptide antibiotics
3. Phylogenetic perspectives in innate immunity
4. Defensins of vertebrate animals
5. Cathelicidins: A family of endogenous antimicrobial peptides
6. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines
7. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action
8. Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins
9. Innate immunity
10. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: Receptors and activities of human defensins and cathelicidin (LL-37)
11. Antimicrobial peptides: An emerging concept in cutaneous biology
12. Expression of the peptide antibiotics human β defensin-1 and human β defensin-2 in normal human skin
13. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic
14. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders
15. Staphylococcus aureus infections
16. Nasal carriage as a source of Staphylococcus aureus bacteremia
17. Innate antimicrobial activity of nasal secretions
18. A peptide antibiotic from human skin
19. Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin
20. Innate antimicrobial peptide protects the skin from invasive bacterial infection
21. Widespread expression of β-defensin hBD-1 in human secretory glands and epithelial cells
22. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6
23. Production of β-defensins by human airway epithelia
24. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis
25. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa
26. Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria
27. Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense
28. Resistance to antimicrobial peptides is necessary for Salmonella virulence
29. Antimicrobial peptides of phagocytes and epithelia
30. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine
31. Unusual mechanism of pathogenicity of Pseudomonas aeruginosa isolates from patients with cystic fibrosis
32. Survival of Staphylococcus aureus inside neutrophils contributes to infection
33. Chronic granulomatous disease in adults
34. Antimicrobial peptides from platelets
35. In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source
36. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2
37. Action of antimicrobial peptides: Two-state model
38. Lipoteichoic acid and teichoic acid biosynthesis. Targets of new antibiotics?
39. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins and other antimicrobial peptides
40. Physiology of lipoteichoic acids in bacteria
41. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity
42. O antigen and lipid A phosphoryl groups in resistance of Salmonella typhimurium LT-2 to nonoxidative killing in human polymorphonuclear neutrophils
43. How intracellular bacteria survive: Surface modifications that promote resistance to host innate immune responses
44. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance
45. Lipid A modifications in polymyxin-resistant Salmonella typhimurium
46. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides
47. Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar Typhimurium
48. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides
49. A PhoP-regulated outer membrane protease of Salmonella enterica serovar Typhimurium promotes resistance to α-helical antimicrobial peptides
50. Further characterization of the PhoP regulon: Identification of new PhoP-activated virulence loci
51. Identification of Legionella pneumophila rcp, a pagP-like gene that confers resistance to cationic antimicrobial peptides and promotes intracellular infection
52. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family
53. Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus
54. In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal proteins is associated with alterations in cytoplasmic membrane fluidity
55. Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: Role of the qacA locus
56. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator
57. How bacteria resist killing by host defense peptides
58. Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia
59. Induction of polymyxin resistance in Pseudomonas fluorescens by phosphate limitation
60. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ
61. The pleiotropic two-component regulatory system PhoP-PhoQ
62. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci
63. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces
64. The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolysins
65. Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin
66. Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli